These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14136290)

  • 1. ADRENALINE, NORADRENALINE AND DOPAMINE EXCRETION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    SERRANO PA; FIGUEROA G; TORRES M; RAMIREZDELANGEL A
    Am J Cardiol; 1964 Apr; 13():484-8. PubMed ID: 14136290
    [No Abstract]   [Full Text] [Related]  

  • 2. ADRENERGIC MECHANISMS IN THE TREATMENT OF ESSENTIAL HYPERTENSION.
    ABRAMS WB; MOE RA; BATES H; WALLEN M; ODZE M; CREWS A; POCELINKO R
    Am J Cardiol; 1963 Nov; 12():711-20. PubMed ID: 14076003
    [No Abstract]   [Full Text] [Related]  

  • 3. TREATMENT OF HYPERTENSION WITH RESERPINE, THIAZIDE DERIVATIVES, AND GUANETHIDINE.
    SEEDAT YK; BHIKHA M; PATEL PL; PILLAY VK
    S Afr Med J; 1964 Apr; 38():282-4. PubMed ID: 14144293
    [No Abstract]   [Full Text] [Related]  

  • 4. THE PHARMACOLOGY OF 3-PHENOXYPROPYLGUANIDINE.
    CHEN G; ENSOR CR; MCCARTHY DA; MCLEAN JR; CAMPBELL A
    J Pharmacol Exp Ther; 1964 Mar; 143():374-82. PubMed ID: 14161151
    [No Abstract]   [Full Text] [Related]  

  • 5. CHEMOTHERAPY OF HYPERTENSION: YESTERDAY--TODAY--TOMORROW.
    SJOERDSMA A
    Circulation; 1963 Aug; 28():161-4. PubMed ID: 14051535
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative clinical trial of guanoxan and guanethidine in essential hypertension.
    Ruedy J; Davies RO
    Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF ADRENERGIC NEURONE BLOCKING AGENTS ON THE RELEASE AND UPTAKE OF CATECHOLAMINES BY THE RAT HEART.
    BHAGAT B
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():231-7. PubMed ID: 14077712
    [No Abstract]   [Full Text] [Related]  

  • 8. [PHARMACOLOGICAL STUDIES ON GUANETHIDINE DERIVATIVES. II. EFFECTS OF SOME DRUGS ON HYPOTENSIVE ACTION OF GUANETHIDINE AND (2-(HEXAHYDRO-1-AZEPINYL)ETHYL)GUANIDINE SULFATE].
    OZAWA H; OHTSUKI I
    Yakugaku Zasshi; 1964 Jan; 84():67-72. PubMed ID: 14107856
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF GANGLION BLOCKING DRUGS ON THE RESPONSES OF THE RABBIT AORTIC STRIP TO ADRENALINE, NORADRENALINE AND OTHER VASOACTIVE SUBSTANCES.
    KELKAR VV; GULATI OD; GOKHALE SD
    Arch Int Pharmacodyn Ther; 1964 May; 149():209-22. PubMed ID: 14169884
    [No Abstract]   [Full Text] [Related]  

  • 10. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECT OF RESERPINE AND GUANETHEDINE ON EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID IN MAN.
    WOODS JW; AJZEN H
    Proc Soc Exp Biol Med; 1963 Oct; 114():107-9. PubMed ID: 14076851
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPARISON OF ALPHA-METHYLDOPA WITH STANDARD ANTIHYPERTENSIVE THERAPY IN MAN.
    KAKAVIATOS N; CHUPKOVICH V; FINNERTY FA
    Am J Cardiol; 1964 Apr; 13():489-94. PubMed ID: 14136291
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of nicotine on coronary vascular resistance in dogs.
    LEADERS FE; LONG JP
    Am J Physiol; 1962 Oct; 203():621-5. PubMed ID: 13928821
    [No Abstract]   [Full Text] [Related]  

  • 14. [DRUG THERAPY OF HIGH BLOOD PRESSURE IN THE PAST, PRESENT AND FUTURE].
    MATHISEN HS
    Tidsskr Nor Laegeforen; 1963 Nov; 83():1679-80. PubMed ID: 14095628
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.
    HERTTING G; AXELROD J; PATRICK RW
    Br J Pharmacol Chemother; 1962 Feb; 18(1):161-6. PubMed ID: 14036196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. URINARY EXCRETION OF CATECHOL AMINES IN THE RAT AFTER THEIR LIBERATION BY RESERPINE OR DEXAMPHETAMINE.
    BISCARDI AM; CARPI A; ORSINGHER OA
    Br J Pharmacol Chemother; 1964 Dec; 23(3):529-39. PubMed ID: 14256812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The depressor action of dopamine and adrenaline.
    BURN JH; RAND MJ
    Br J Pharmacol Chemother; 1958 Dec; 13(4):471-9. PubMed ID: 13618554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pentolinium on sympathetic activity in hypertensives and normotensive controls.
    Murphy MB; Brown MJ; Causon RC; Dollery CT
    Int J Clin Pharmacol Res; 1983; 3(4):227-32. PubMed ID: 6678820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor effects of adrenaline, noradrenaline and reflex vasoconstriction sensitised by low concentrations of ganglion blocking drugs.
    MAWJI S; LOCKETT MF
    J Pharm Pharmacol; 1963 Jan; 15():45-55. PubMed ID: 13934052
    [No Abstract]   [Full Text] [Related]  

  • 20. CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.).
    MOE RA; BATES HM; PALKOSKI ZM; BANZIGER R
    Curr Ther Res Clin Exp; 1964 Apr; 6():299-318. PubMed ID: 14173509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.